Prosecution Insights
Last updated: July 17, 2026
Application No. 17/429,015

FLEXOGRAPHIC PRINTING RAW PLATE AND MANUFACTURING METHOD OF FLEXOGRAPHIC PRINTING PLATE

Final Rejection §102§103
Filed
Aug 06, 2021
Priority
Feb 27, 2019 — JP 2019-034366 +2 more
Examiner
CHU, JOHN S Y
Art Unit
1737
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Asahi Kasei Kabushiki Kaisha
OA Round
5 (Final)
77%
Grant Probability
Favorable
6-7
OA Rounds
0m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 77% — above average
77%
Career Allowance Rate
749 granted / 971 resolved
+12.1% vs TC avg
Moderate +6% lift
Without
With
+5.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
49 currently pending
Career history
1034
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
75.6%
+35.6% vs TC avg
§102
12.8%
-27.2% vs TC avg
§112
6.3%
-33.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 971 resolved cases

Office Action

§102 §103
DETAILED CORRESPONDENCE This Office action is in response to the amendment received March 17, 2026. Bold text in the Office action indicates new language. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1, 3-5, 7 and 10-21 are rejected under 35 U.S.C. 102(a) (1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over LEINENBACH et al (6,521,390), as evidenced by KOZIMA et al (4,301,224,) MINAMIKAWA (2019/0232612), ZEIGLER (5,520,756) FAN (6,929,898), and FAN (5,719,009). The claimed invention now recites the following: PNG media_image1.png 498 684 media_image1.png Greyscale LEINENBACH et al report an IR ablatable layer over a photopolymerizable layer where a cover layer is initially removed in a flexographic printing plate. The IR layer is noted to have a dispersant such as commercially available Solsperse 28000 which discloses a base number of 45 mgKOH/g as seen in column 7, lines 1-20 and falls within the claimed range in claim 1. The use of Solsperse is in Example 1, see below: The claimed flexographic printing plate is anticipated by the Example in LEINENBACH et al. With respect to claim 2, the difference between the solubility parameters of the binder polymer and the dispersant is not explicitly disclose, however the use of nitrocellulose binder [polyamide] layer in LEINENBACH et al would inherent be present due to the identical dispersant used in LEINENBACH et al and the disclosure of the same or similar binders disclosed, see Example 1 below: Claim 3 recites carbon black which is reported in Example 1 in column 6, lines 63- column 7, line 25. PNG media_image2.png 108 446 media_image2.png Greyscale PNG media_image3.png 376 472 media_image3.png Greyscale For claim 4, the Mw is inherently disclosed to meet the claimed limitation wherein the same or similar dispersant is disclosed. Claim 5-6 is met by the Example 1. With respect to claim 7 applicants are directed to column 5, lines 37-45, for intermediate layer, see below: PNG media_image4.png 174 470 media_image4.png Greyscale Claims 10-20 is met by Example 1 explicitly or inherently for the parts of the parts by mass of the dispersant to 100 parts by mass of the infrared absorber. Example 1 discloses 1.1 parts by mass of the dispersant to 100 parts by weight of the carbon black (.025/2.3). KOZIMA et al is cited to disclose the solubility parameter (SP) of nitrocellulose to be 10.7-11.4, see Table 2 from column 6: PNG media_image5.png 482 370 media_image5.png Greyscale MINAMIKAWA and ZEIGLER verify the SP of nitrocellulose by disclosing values in those ranges reported in KOZIMA et al, see page 6, para. [0096] in MINAMIKAWA and column 3, lines 45-50 in ZEIGLER below, respectively: PNG media_image6.png 82 370 media_image6.png Greyscale PNG media_image7.png 94 416 media_image7.png Greyscale The difference between the SP values of nitrocellulose and Solsperse 28000 as seen in LEINENBACH et al would meet the claimed absolute between 0.3 and 4 (cal/cm3)1/2 . FAN discloses a flexographic printing plates wherein the infrared ablation layer can include a number of binders, such as polymethyl methacrylate, see below: PNG media_image8.png 432 384 media_image8.png Greyscale PNG media_image9.png 408 388 media_image9.png Greyscale FAN ‘009 disclose flexographic printing plates comprising at least one layer of an infrared radiation sensitive material capable of being exposed to laser ablation., col. 2, lines 29-36 below: PNG media_image10.png 112 388 media_image10.png Greyscale FAN teaches a barrier layer is interposed between the photopolymerizable layer and the infrared sensitive layer binders to minimize migration of materials between the layers and to shield the photopolymerizable layer from atmospheric oxygen. Binder that can be used in the infrared sensitive layers include nitrocellulose and styrene, butadiene , isoprene and their copolymers and block copolymers teaching the skilled artisan the functional equivalent of those binders as reported in col. 7, lines 19-27, see below: PNG media_image11.png 528 388 media_image11.png Greyscale New claim 21 is met by the values for styrene/butadiene copolymer in Table 2 of KOJIMA arriving at an absolute value of the difference between the dispersant (Solsperse 28000) and the binder if used in the Example of LEINENBACH which is in the range of 2.96-2.3. It would have been prima facie obvious to one of ordinary skill in the art of flexographic printing plates to duplicate Examples 1 of LEINENBACH for the infrared ablation layer which comprises any of the listed binders in FAN such as styrene/butadiene copolymers as reported in FAN ‘009 formulated with SOLSPERSE 28000 wherein the difference of the SP of the styrene/butadiene resin and the SP of Solsperse 28000 would gave an absolute value of in a range of 2.96 to 2.3 (using values taken from Table 2 of KOZIMA thus meeting the claimed range of 0.3 and 4 (cal/cm3 )1/2 as well as the range recited in new claim 21 (0.3 to 2.9 (cal/cm3 )1/2 with the reasonable expectation of same or similar results for excellent flexibility and sensitivity. The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. VAN ZOEREN (5,506,086) discloses that if a barrier layer is interposed between the infrared sensitive layer and the photopolymer layer, optional binders that further include elastomeric polymers that are same or similar to the elastomeric binders used in the photopolymer layer can be formulated in the infrared sensitive layers. JONES (4,070,388), ASHE (4,032,698), THOMPSON (3,788,996) and BRAUN (3,684,771) report A-B dispersants suitable when a pigment is present in the infrared sensitive layer in order to disperse the fine particles and avoid flocculation and agglomeration , see col. 8, lines 11-22 in FAN ‘009. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN S CHU whose telephone number is (571)272-1329. The examiner can normally be reached M-F, IFP-Flex. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Huff, can be reached at telephone number 571-272-1385. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://portal.uspto.gov/external/portal. Should you have questions about access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. /John S. Chu/ Primary Examiner, Art Unit 1737 J. Chu May 27, 2026
Read full office action

Prosecution Timeline

Show 11 earlier events
Jul 07, 2025
Non-Final Rejection mailed — §102, §103
Oct 06, 2025
Response Filed
Dec 23, 2025
Non-Final Rejection mailed — §102, §103
Feb 20, 2026
Interview Requested
Mar 03, 2026
Examiner Interview Summary
Mar 03, 2026
Applicant Interview (Telephonic)
Mar 17, 2026
Response Filed
Jun 01, 2026
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12681385
PHOTOSENSITIVE RESIN COMPOSITION AND MANUFACTURING METHOD OF DISPLAY DEVICE USING THE SAME
3y 12m to grant Granted Jul 14, 2026
Patent 12663714
RESIST COMPOSITION AND PATTERN FORMING PROCESS
2y 11m to grant Granted Jun 23, 2026
Patent 12663715
PHOTOSENSITIVE RESIN FILM AND APPLICATION THEREOF
2y 3m to grant Granted Jun 23, 2026
Patent 12645142
A PHOTORESIST COMPOSITION, A METHOD FOR MANUFACTURING A PHOTORESIST COATING, ETCHED PHOTORESIST COATING, AND ETCHED SI CONTAINING LAYER(S), AND MANUFACTURING A DEVICE USING THEREOF
5y 5m to grant Granted Jun 02, 2026
Patent 12625427
NOVEL NAPHTHALIMIDE SULFONATE DERIVATIVE, AND PHOTOACID GENERATOR AND PHOTORESIST COMPOSITION EACH COMPRISING SAME
2y 10m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

6-7
Expected OA Rounds
77%
Grant Probability
83%
With Interview (+5.6%)
2y 11m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 971 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month